Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
4-1-2022

Early expression of MMP-9 predicts recovery of tibialis anterior
after sciatic nerve crush injury
David M Brogan
Christopher J Dy
Jason Wever
Tony Lee
Samuel Achilefu

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Original Article

Peripheral Nerve
Early Expression of MMP-9 Predicts Recovery of
Tibialis Anterior after Sciatic Nerve Crush Injury
David M. Brogan, MD, MSc*
Christopher J. Dy, MD, MPH*
Jason Wever, MS*
Tony Lee, BA*
Samuel Achilefu, PhD†
Downloaded from http://journals.lww.com/prsgo by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 05/17/2022

Background: The purpose of this study was to assess the expression of molecular
markers and epineural blood flow after differing degrees of nerve injury to identify
potential tools to predict nerve recovery in a rat sciatic nerve model.
Methods: A total of 72 rats were divided into nine groups. Each group was subjected
to one of three crush injuries, created by applying one of three vascular clamps for
30 seconds. Vascularity was assessed with laser Doppler flowmetry before and after
crush, and at nonsurvival surgery. Nonsurvival surgeries were performed 6 hours, 2
weeks, or 6 weeks later with nerve conduction studies and muscle strength testing.
Expression of matrix metalloproteinase 9 (MMP-9) and matrix metalloproteinase 2
(MMP-2) in each nerve was quantified using with enzyme linked immunosorbent
analysis.
Results: Persistent hyperemia was noted in the zone of injury compared with
baseline at 2 weeks and 6 weeks in the groups that displayed incomplete recovery. Expression of MMP-9 at 6 hours increased with increasing severity of crush
and was inversely related to tibialis anterior muscle force recovery. The ratio of
MMP-9:MMP-2 expression correlated well with recovery of compound nerve action
potential amplitude at 6 weeks.
Conclusions: Resolution of nerve hyperemia may correlate with nerve recovery
from trauma, but early measures of nerve blood flow after injury are not prognostic of recovery. Ratio of MMP-9:MMP-2 expression 6 hours after injury correlates with recovery of compound nerve action potential at 6 weeks, while MMP-9
expression alone predicts tibialis anterior recovery. These findings together
suggest that increased MMP-9 expression is a potentially useful marker of more
severe nerve injury. (Plast Reconstr Surg Glob Open 2022;10:e4260; doi: 10.1097/
GOX.0000000000004260; Published online 18 April 2022.)

INTRODUCTION

Traumatic nerve injuries occur in approximately
2%–3%1,2 of major limb traumas, causing significant
pain, disability, and economic hardship. Distinguishing
a critically injured nerve is key to appropriate treatment,
as 97% of patients with Sunderland grade 1 injuries
(neurapraxia)3,4 regain normal function, while 83% of
those with Sunderland grade 5 injuries (complete nerve
transection) achieve little to no functional recovery.2
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Unfortunately, electrodiagnostic studies can produce
unreliable results within the first 3–6 weeks after nerve
injury.5 Therefore, a critical need exists to identify physiologic or molecular markers corresponding to severity of
nerve injury. Recent investigations have explored alterations in neural vascularity and expression of inflammatory markers after chronic compression,6 but less is
known about traumatic injury. Prior work at other institutions has demonstrated a local increase in matrix metalloproteinase 9 (MMP-9) 6 hours after peripheral nerve
injury.7 MMP-9 has been implicated in NGF-mediated
neurite elongation8 and is upregulated in models of
murine neurotrauma.9 In sharp contrast, matrix metalloproteinase 2 (MMP-2) is found within healthy nerves,
and has different temporal expression than MMP-9 after
injury. The release of pro-inflammatory cytokines such
as MMP-9, IL-1, and TNF-alpha after peripheral nerve
injury leads to degradation of the blood-nerve barrier
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and recruitment of macrophages to facilitate myelin
clearance and nerve regeneration.10
New techniques in intraoperative imaging could be
utilized to allow noninvasive assessment of such molecular markers with fluorophore probes and aid in surgical
decision making.11,12 The central hypothesis of this article
is that a graduated crush injury to a peripheral nerve will
result in a proportional change to epineural blood flow
and changes in expression of MMP-9 and MMP-2.

METHODS

To assess the effect of severity of injury on blood flow
and MMP expression, a graduated crush model was developed using three vascular clamps. A total of 72 Lewis rats
were divided into three separate groups of 24 each, with
each group subjected to one of three degrees of unilateral
sciatic nerve crush injury. All protocols were approved by
our Institutional Animal Care and Use Committee. Baseline
epineural blood flow was measured in the bilateral sciatic
nerves using laser Doppler flowmetry and a crush injury
then applied unilaterally with a vascular clamp. Eight rats
in each crush group underwent nonsurvival procedures at
6 hours, 2 weeks, and 6 weeks to measure epineural blood
flow and assess histology, nerve conduction, and muscle
strength.
Validation of the Crush Injury

Three vascular clamps were obtained (Roboz Surgical
Instrument Co., Gaithersburg, Md.), including a Johns
Hopkins bulldog clamp, a DeBAKEY atraumatic bulldog
clamp, and a Glover straight atraumatic bulldog clamp. Ultra
Low Pressure Fuji film Prescale (FUJI CORP) was utilized to
assess the pressure applied to each nerve. Each clamp was
applied to the film for 30 seconds, and each trial performed
seven times. Pressure maps were digitized and analyzed with
ImageJ.13 RGB pixel intensity of the exposed image was calculated and compared with a colorimetric scale.
Survival Surgery

Isoflurane anesthesia was utilized for sedation, and a
transgluteal approach was made to the sciatic nerve. A
reference point was marked with a 9-0 nylon 6 mm proximal to the sciatic trifurcation. Epineural red blood cell
flux was measured with a laser Doppler flowmeter (Moor
Instruments, Inc, Devon, UK) centered on the suture
(Fig. 1). A region of interest was measured proximal and
distal to the suture.
One of the clamps was applied to the nerve distal to
the epineural suture for 30 seconds, released and applied
again distal to the previous area for a crush width of 5 mm.
Flowmetry measurements were taken again (Fig. 2). The
contralateral sciatic nerve was exposed, suture placed, and
flowmetry measured. Incisions were closed, and animals
given oral Carprofen daily for 72 hours.
Nonsurvival surgery

Nonsurvival surgeries were performed at 6 hours, 2
weeks, and 6 weeks. Anesthesia was induced, the incisions
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Takeaways
Question: Can laser Doppler flowmetry and MMP expression predict potential for recovery after nerve crush?
Findings: Rat sciatic nerves were subjected to differing
degrees of crush injury and assessed with laser Doppler
flowmetry. Early measurements of laser Doppler flowmetry
immediately after crush did not differentiate the degree of
nerve crush. Early expression of MMP-9 reflected potential for late recovery of tibialis anterior function.
Meaning: Molecular markers expressed in nerves early
after injury, such as MMP-9 and MMP-2, may be useful in
predicting potential for clinical recovery at 6 weeks.

were re-opened, and laser Doppler flowmetry measurements were obtained of the same region of interest for
both control and experimental sides, followed by nerve
conduction studies and muscle force measurements. The
injured nerve was harvested, samples from the nerve
proximal to and within the zone of injury were preserved
for with enzyme linked immunosorbent analysis assays of
MMP-9 and MMP-2, histomorphologic measurements,
and immunohistochemistry.
Measurement of MMP-2 and MMP-9 Expression

Quantification of MMP-9 and MMP-2 protein expression was accomplished with enzyme linked immunosorbent analysis using commercially prepared kits for
MMP-9 (Aviva Systems Biology, San Diego, Calif.) and
MMP-2 (ScienCell Research Laboratories, Carlsbad,
Calif.). A 2-mm section was taken from the injured and
uninjured portion of the nerve, protein was extracted
using N-PER Neuronal Protein Extraction Reagent
(Thermo Scientific #87792), and total protein concentrations were measured using Pierce Coomassie
Plus (Bradford) Assay kit (Thermo Scientific #23236).
Protein samples were diluted to equal concentrations
for all samples, 10 μg/mL for MMP-9 assay and 50 ug/
mL for MMP-2 assay; all enzyme linked immunosorbent
analysis assays were performed in 96-well, optical-bottom
plates. Similar samples were harvested from the control
nerve and analyzed.
Electrodiagnostic Studies

A functional assessment system (Red Rock
Laboratories, St. Louis, Mo.) was utilized to asses compound nerve action potential latency and amplitude
bilaterally. The stimulus probe was placed on the sciatic
nerve just proximal to the crush, and the recording probe
placed on the common peroneal nerve at least 1 cm apart.
For nerve conduction study recordings, the stimulus was
1000 μA with a pulse duration of 50 μs. Once two satisfactory waveforms were captured, the average amplitude and
latency were recorded.
Maximal tetanic force of bilateral tibialis anterior and
gastrocnemius muscles was measured. Tendons were transected and sutured to metal hooks connected to the transducer using 5-0 nylon suture after immobilizing the knee
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Fig. 1. Experimental setup of laser Doppler flowmetry before exposure, flowmetry measurement, and
crush injury to nerve.

Fig. 2. Laser Doppler flowmetry was utilized to assess blood flow in control and injured nerves before
and after injury. Flowmetry image as measured by laser Doppler demonstrating hyperemia in crushed
nerve (B) compared with baseline. Control nerve (A) demonstrates no significant change at 2 weeks.

with a rigid clamp. The sciatic nerve was stimulated proximal to the injury with a stimulus signal of 1000 μA, burst
width of 0.3 s, pulse duration 200 μs, and frequency 80 Hz.
Tendon length/tension was adjusted to achieve maximal
isometric tetanic force with a consistent waveform.
Experimental and control sciatic nerves were harvested and prepared for immunohistochemistry and histormorphologic analysis to include total axon counts and
G-ratio. Samples were incubated with primary antibodies

to axonal neurofilaments, MMP-9, MMP-2, and CD31,
followed by a wash, blocking and fluorescent secondary
antibodies.
Statistical Analysis

One-way ANOVA was used to compare FUJI film pixel
intensity after crush validation for each clamp. Mixed effects
analysis was used to compare flowmetry data, and histomorphometry data, including G-ratio and normalized total
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number of axons in the zone of injury for each of the clamps
at each time point. All flux values were reported as a ratio
of the value at each time point compared with its pre-injury
flux. One-way ANOVA tests were also used to compare
CNAP amplitude, CNAP latency, and gastrocnemius and
tibialis anterior muscle forces, between the different crush
groups at each time interval. MMP-9 and MMP-2 expression were also calculated as a ratio of the expression of each
protein compared with the uninjured zone proximal to the
crush injury and compared amongst injury groups at each
time interval using one-way ANOVA. A Dunnett’s test was
used to adjust for the effect of multiple comparisons at each
time point for one-way ANOVA, and Tukey’s multiple comparisons test was utilized for the mixed effects model.
Sample Size Justification

A-priori power analysis found that MMP-9 expression
was expected to increase in the zone of injury in the
severe crush group, based on a literature review of work
in a chronic compression model.6 A sample size of eight
per group at each time point (total 72 rats) achieves
80% power to detect a 68% increase in expression of
MMP-9 ratio between the crush levels assuming a null
hypothesis of no difference between the crush severity
and a significance level of 0.05 using an analysis of variance F-test.

RESULTS
Force Validation

Results of the pressure film measurements demonstrated that the Hopkins bulldog clamp exerted a mean
pressure of 0.393 MPa, the Debakey clamp exerted a
pressure of 0.455 MPa, and the Glover bulldog clamp
resulted in 0.683 MPa. One-way ANOVA showed a significant difference in pixel intensity on FUJI film between
the Hopkins bulldog and Glover bulldog crush groups
(P = 0.01), and between the Debakey and the Glover bulldog clamps (P = 0.03). No significant difference was found
between the Hopkins bulldog clamp and the Debakey
clamp (P = 0.71). To simplify nomenclature, each of
these clamps was designated as mild A (Hopkins), mild B
(Debakey), and severe (Glover), respectively (Fig. 3).
Flowmetry Data

All but two of the rats survived throughout the study;
these two (both from mild B group) were removed and
subsequently replaced to ensure adequate numbers.
All nerves undergoing surgery demonstrated increased
hyperemia at 6 hours after the index surgery, but no significant difference was found between groups. The mild
B crush and severe crush maintained persistently elevated
red blood cell flux levels (hyperemia) compared with

Fig. 3. Crush injuries were validated using Fuji film. Prescale ultra low pressure film demonstrating pressure maps from mild A, mild B and severe crush injuries (A) with calculated average pixel intensity as
measured in ImageJ. (B).
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controls at 2 weeks (with a mean difference of −0.61 flux
units; 95%CI [−0.87, −0.37] and −0.65 flux units; 95%CI
[−0.90, −0.40]) (Fig. 4). This difference in flux persisted
even at 6 weeks in the mild B and severe crush groups
compared with controls, but the magnitude of difference
did not correlate with severity of injury (−0.47 flux units;
95%CI [−0.64, −0.29] for mild B and −0.32 flux units;
95%CI [−0.59, −0.06] for severe).
Nerve Conduction Studies

Nerve conduction studies demonstrated no change in
latency at 6 hours but a uniformly significant increase in
latency among all groups when compared with controls
at 2 weeks (Fig. 5A). However, this increase was transient,
with a return to normal latency by 6 weeks in all groups
(P = 0.46). A significant drop in amplitude was seen in
all crushed nerves at 6 hours postinjury, and diminished
amplitude persisted in all groups at both 2 weeks and
6 weeks compared with controls (P < 0.0001 for both)
(Fig. 5B). Intergroup comparison at 6 weeks between varying degrees of crush demonstrated persistent amplitude
difference between the mild A and severe injury (mean
difference of 1.47 mV; 95%CI [0.33, 2.60]) but no significant difference in amplitude between the mild A and
mild B groups (mean difference 0.54 mV; 95%CI [−0.60,
1.67]), or the mild B and severe groups (mean difference
0.93 mV; 95%CI [−0.21, 2.07]).
Muscle Force Testing

At the 6 hour and 2 week time points, all injured
legs demonstrated a significant decrease in both

gastrocnemius and tibialis anterior force compared with
controls (P < 0.0001). By 6 weeks, no significant difference
was observed in gastrocnemius muscle strength between
injured and control groups (Fig. 6A). Tibialis anterior
muscle force proved to have a slower recovery in comparison to the gastrocnemius muscle. In contrast, all crush
groups had significantly diminished tibialis anterior muscle strength compared with control (P < 0.0001) at 2 weeks
and showed significant differences in recovery between
the crush groups. At 6 weeks, the mild A crush group had
regained strength equivalent to the controls, whereas mild
B had slightly less strength compared with controls. The
severe crush demonstrated significant persistent weakness, compared with control 4.02 N; 95%CI [3.28,4.75])
and the other crush groups (Fig. 6B).
Histomorphometry

The total number of axons at 6 hours did not vary
between groups, but was significantly different amongst all
groups at 2 weeks. A significant difference was also seen in
the severe crush at 6 weeks compared with the two milder
injuries (Fig. 7A). G-ratio was also significantly different
amongst all groups at 2 weeks, and this difference persisted in the severe crush injury compared with the mild
crush injuries, even at 6 weeks (Fig. 7B).
MMP-2 and MMP-9 Expression

Severe crush demonstrated a significant increase in
MMP-9 expression compared with controls (P < 0.0001)
6 hours after injury, but this was not found in mild A
(P = 0.9923) or mild B (P = 0.075) crush injuries (Fig. 8A).
However, severe crush did demonstrate an increase in
MMP-9 expression compared with the mild A and mild B
crushes (P < 0.0001). No significant difference was found
in MMP-9 expression between any group at 2 or 6 weeks.
MMP-2 was uniformly decreased in the crushed area compared with control with all degrees of crush at 6 hours
(P < 0.0001), but significantly elevated compared with controls in all groups at 2 weeks. By 6 weeks, MMP-2 expression demonstrated no significant difference between crush
and control groups. The ratio of MMP-9 to MMP-2 at 6
hours postinjury in the severe crush group demonstrated
an increase three times greater than that seen in the mild
A crush (mean difference −4.59; 95%CI[−5.96, 3.21]
and −1.43; 95%CI[−2.81, −0.06] respectively) (Fig. 8B).
Immunohistochemistry stains confirmed the presence of
MMP-9 within 6 hours of injury (Fig. 9).

DISCUSSION

Fig. 4. Flux ratios compared with pre-crush baseline measurement.
Persistent increased flux was noted in the more severely injured
groups at 2 weeks and 6 weeks.

The results of this study suggest that laser Doppler
flowmetry and MMP-9 expression correlate with degree of
nerve injury, but at differing timepoints. Early changes in
laser Doppler flowmetry did not predict long-term recovery, but persistent nerve hyperemia at 6 weeks was indicative of incomplete tibialis anterior recovery and likely
reflects persistent disruption in the blood nerve barrier
(BNB) associated with incomplete axonal regeneration.
This finding is in agreement with prior studies showing
increased signal on T2-weighted MRI images for up to 2
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Fig. 5. CNAP latency and amplitude were calculated in injured and control nerves during non-survival surgery. A, CNAP latency measurements at different time intervals. Note significant elevation in latency 2 weeks after injury, which returned to normal by 6 weeks. B, CNAP
amplitude decreased immediately and did not fully recover after 6 weeks in any group, consist with axonotmetic injury.

Fig. 6. Maximal isometric tetanic force was assessed in each hindlimb during non-survival surgery A, Gastrocnemius muscle force correlated to degree of injury at 2 weeks, with complete recovery across all groups at 6 weeks. B, Tibialis anterior muscle force correlated with
degree of injury and time from injury at both 2 weeks and 6 weeks, with persistent dysfunction in the most severe injuries.

weeks14 after a rat sciatic nerve crush injury. A separate
rodent model of axonotmetic nerve injury demonstrated
that return of normal CMAP occurred within 2 weeks of
resolution of T2-weighted signal enhancement,15 while
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others have found persistent nerve enhancement on MRI
3 weeks after crush.16 Although we did not use MRI, the
persistent hyperemia seen at 2 weeks in two of the three
groups likely corresponds with signal enhancement seen

Brogan et al. • Perfusion and MMP-9 Expression in Nerve Crush

Fig. 7. Histomorphometric measurements of injured nerves were obtained and normalized against the contralateral control nerve. A,
Total number of axons correlated with time from injury and degree of crush. B, G-ratio within the zone of injury at different time points
varied by degree of crush.

Fig. 8. ELISA assay was used to calculate MMP-9 and MMP-2 expression in injured and control nerves. A, Expression of MMP-9 in the
crushed portion of nerve as a ratio of the expression in the more proximal uninjured portion of nerve at differing time points. B, Expression
of MMP-9:MMP-2 in the crushed portion of nerve compared with the uninjured portion at 6 hours corresponded to recovery of CNAP
amplitude at 6 weeks.

on T2 images due to disruption of the BNB. Bouldin et
al17 found that the presence of regenerating axons correlated with restoration of impermeability of the BNB, as did

Omura, who noted that the restoration of the BNB occurs
in a proximal to distal direction and lags behind nerve
regeneration by 1 week.18
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Fig. 9. Confocal microscopy with immunohistochemical stains of
injured nerve demonstrating presence of MMP-9 within the zone of
injury 6 hours after severe crush.

Total axon count and muscle force are thought to be
sensitive indicators of nerve regeneration in crush injuries.19 Our findings of persistent tibialis anterior weakness and reduced total axon count at 6 weeks validate
a clear distinction between the milder and more severe
crush injuries to the peroneal division of the sciatic nerve.
Previously published animal models of mild nerve crush
injuries mimic the clinical scenario of a grade 2 crush,
with subsequent Wallerian degeneration, and recovery
by 2–3 weeks.20,21 In contrast, we induced a severe crush
resulting in a persistent difference in tibialis anterior force
but not gastrocnemius force at 6 weeks. Similar findings of
earlier recovery of plantarflexion at 6 weeks, with incomplete dorsiflexion recovery have been reported in a rat
sciatic nerve model.22

Curiously, our G-ratio did not mirror functional recovery; however, a relatively poor correlation between G-ratio
and nerve conduction velocity has been described and
likely reflects a mix of small and large diameter fibers with
varying degrees of myelin.23 This is consistent with changes
in G-ratio between groups at different time points in our
data, which appeared to be related to wide variations in
fiber size in the more severe crush group (Fig. 10).
Finally, we found a proportional early increase in MMP-9
expression with increasing degree of crush severity, likely
reflective of more severe injury to Schwann cells with a
resulting increased inflammatory cascade.24,25 Furthermore,
significant increases in MMP-9 expression at 6 hours postinjury were able to predict recovery of tibialis anterior muscle
force and total number of axons at 6 weeks. The ratio of
MMP-9:MMP-2 at 6 hours inversely corresponded to the
CNAP amplitude at 6 weeks but did not predict muscle
recovery. This ratio likely reflects the severity of intraneural fibrosis conferred by each of the nerve injuries. Indeed,
intraoperative ultrasound evaluation of traumatic nerve
injuries has demonstrated decreased CNAP amplitudes in
more severe injuries with significant intraneural scarring.26
MMP-9 expression alone showed a sharp rise at 6 hours,
but this was not sustained at 2 weeks or 6 weeks in any of
the crush mechanisms, as previously reported.7 Although
MMP-9 is scarce in normal Schwann cells, it is upregulated
in axonal injury.27 Our results showed an increase in latency
at 2 weeks, but not at 6 hours despite an early drop in CNAP
amplitude. Stecker et al found similar results in an acute
nerve compression model, where CMAP amplitude (but not
latency) significantly declined immediately after injury.28
Late changes in latency in our data likely represent the
sequelae of Wallerian degeneration via myelin breakdown
and the subsequent transdifferentiation of Schwann cells
into a pro-regenerative phenotype to aid in nerve recovery.29 MMP-2 is expressed in normal nerves but increases
in expression 5 days after injury, peaks around 10 days,
and remains elevated for up to 9 weeks.30 Given the above,
MMP-9 may prove to be a sensitive prognostic marker of
functional nerve recovery, while the ratio of MMP-9:MMP-2
may better predict overall axonal injury.

Fig. 10. Photomicrographs of representative zones of nerve injury taken at 2 weeks and 6 weeks. More
severe injury resulted in disorganized repair with lower percent nerve.
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This study is not without limitations. The rat sciatic
nerve model may prove to be more resilient to nerve
injury than human models, potentially leading to imperfect correlation of these findings to the clinical setting.
More investigation is needed before this can be applied
clinically, as MMP-9 did not predict gastrocnemius muscle
strength at 6 weeks, suggesting that it may only be useful
to identify the most severe nerve injuries. Despite this, this
study raises interesting questions about the exploitation of
the inflammatory cascade to quantify nerve injury. Work is
currently underway in our laboratory to better understand
the inflammatory response of nerve injury in a nerve transection model and to create molecular markers specific
for MMP-9.
To our knowledge, clinical data are lacking regarding
the timing and degree of MMP-9 expression in human
peripheral nerve injury. Further translational research
may pave the way for applications of novel molecular tracers sensitive to MMP-9 that might be used clinically in the
operating room to assess nerve injury. Optical measurements of fluorescence could then negate the need for
nerve biopsies to assess MMP-9 activity. Given the lack
of sufficient tools for intraoperative evaluation of nerve
injuries, there is an inherent need for new technologies to
assist with identification of degree of nerve injury to allow
for prognostication of recovery, but more investigation is
needed to optimize this technology.
David M. Brogan, MD, MSc
Department of Orthopaedic Surgery
Washington University
425 S. Euclid Ave.
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